Mid-Afternoon Market Update: Arrowhead Pharma Tumbles Following EX-1 RNAi Program Discontinuations; Arbutus Biopharma Shares Surge

By: via Benzinga
Toward the end of trading Wednesday, the Dow traded up 0.35 percent to 19,187.89 while the NASDAQ declined 0.68 percent ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.